States' implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence

Drug and Alcohol Dependence

Volumn 157, Issue , 2015, Pages 36-43

  Knudsen, Hannah K ^a   Lofwall, Michelle R ^a   Havens, Jennifer R ^a   Walsh, Sharon L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Affordable Care Act; Buprenorphine; Health insurance exchanges; Medicaid expansion; Physician supply

Indexed keywords

BUPRENORPHINE;

ARTICLE; CONTROLLED STUDY; GEOGRAPHIC DISTRIBUTION; GROWTH CURVE; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MEDICAID; MIXED EFFECTS REGRESSION ANALYSIS; OBSERVATIONAL STUDY; OPIATE ADDICTION; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGRESSION ANALYSIS; UNITED STATES; LEGISLATION AND JURISPRUDENCE; OPIOID-RELATED DISORDERS; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; TRENDS;

BUPRENORPHINE; DRUG PRESCRIPTIONS; HUMANS; MEDICAID; OPIOID-RELATED DISORDERS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHYSICIANS; PROSPECTIVE STUDIES; UNITED STATES;

EID: 84951840777     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.09.032     Document Type: Article

References (59)

1. Andrews C.M. The relationship of state Medicaid coverage to Medicaid acceptance among substance abuse providers in the United States. J. Behav. Health Serv. Res. 2014, 41:460-472.
2. Arfken C.L., Johanson C.E., di Menza S., Schuster C.R. Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: national surveys of physicians. J. Subst. Abuse Treat. 2010, 39:96-104.
3. Auriacombe M., Fatseas M., Dubernet J., Daulouede P., Tignol J. French field experience with buprenorphine. Am. J. Addict. 2004, 13:S17-S28.
4. Bachhuber M.A., Saloner B., Cunningham C., Barry C.L. Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern. Med. 2014, 174:1668-1673.
5. Bagley N., Jones D.K., Stoltzfus Jost T. Predicting the fallout of King v. Burwell - exchanges and the ACA. N. Engl. J. Med. 2015, 372:101-104.
6. Beronio K., Glied S., Frank R. How the Affordable Care Act and Mental Health Parity and Addiction Equity Act greatly expand coverage of behavioral health care. J. Behav. Health Serv. Res. 2014, 41:410-428.
7. Blumenthal D., Collins S.R. Health care coverage under the Affordable Care Act - a progress report. N. Engl. J. Med. 2014, 371:275-281.
8. Buck J.A. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff. (Millwood) 2011, 30:1402-1410.
9. Buttorff C., Andersen M.S., Riggs K.R., Alexander G.C. Comparing employer-sponsored and federal exchange plans: wide variations in cost sharing for prescription drugs. Health Aff. (Millwood) 2015, 34:467-476.
10. Carrieri M.P., Amass L., Lucas G.M., Vlahov D., Wodak A., Woody G.E. Buprenorphine use: the international experience. Clin. Infect. Dis. 2006, 43:S197-S215.
11. Center for Substance Abuse Treatment Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction (Treatment Improvement Protocol #40) 2004, Substance Abuse and Mental Health Services Administration, Rockville, MD.
12. Centers for Disease Control and Prevention's National Center for Health Statistics Multiple cause of death 1999-2013 on CDC WONDER online database 2015, http://wonder.cdc.gov/mcd-icd10.html (accessed 29.01.15).
13. Cooper R.A. Regional variation and the affluence-poverty nexus. JAMA 2009, 302:1113-1114.
14. Dick A.W., Pacula R.L., Gordon A.J., Sorbero M., Burns R.M., Leslie D., Stein B.D. Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002-11. Health Aff. (Millwood) 2015, 34:1028-1034.
15. Fatseas M., Auriacombe M. Why buprenorphine is so successful in treating opiate addiction in France. Curr. Psychiatry Rep. 2007, 9:358-364.
16. Garfield R.L., Druss B.G. Health reform, health insurance, and mental health care. Am. J. Psychiatry 2012, 169:675-677.
17. Garfield R.L., Lave J.R., Donohue J.M. Health reform and the scope of benefits for mental health and substance use disorder services. Psychiatr. Serv. 2010, 61:1081-1086.
18. Gluck A.R. A legal victory for insurance exchanges. N. Engl. J. Med. 2014, 370:896-899.
19. State decisions for creating health insurance exchanges, as of May 28, 2013 2013, Henry J. Kaiser Family Foundation, https://web.archive.org/web/20130706084344/http://kff.org/health-reform/state-indicator/health-insurance-exchanges/ (accessed 10.06.13).
20. Status of state action on the Medicaid expansion decision, as of May 30, 2013 2013, Henry J. Kaiser Family Foundation, https://web.archive.org/web/20130603184217/http://kff.org/medicaid/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/ (accessed 10.06.13).
21. Health insurance coverage of the total population 2014, Henry J. Kaiser Family Foundation, https://web.archive.org/web/20140712184316/http://kff.org/other/state-indicator/total-population/ (accessed 13.05.14).
22. Status of state action on the Medicaid expansion decision 2015, Henry J. Kaiser Family Foundation, https://web.archive.org/web/20150604004607/http://kff.org/health-reform/state-indicator/state-activity-around-expanding-medicaid-under-the-affordable-care-act/ (accessed 05.06.15).
23. Hill S.C., Abdus S., Hudson J.L., Selden T.M. Adults in the income range for the Affordable Care Act's Medicaid expansion are healthier than pre-ACA enrollees. Health Aff. (Millwood) 2014, 33:691-699.
24. Hinkle L.E. New regulations in the administration of buprenorphine, part one 2015, https://web.archive.org/web/20150623171414/http://www.natlawreview.com/article/new-regulations-administration-buprenorphine-part-one (accessed 23.06.15).
25. Holahan J., Headen I. Medicaid coverage and spending in health reform: National and state-by-state results for adults at or below 133% FPL 2010, http://www.kff.org/healthreform/upload/Medicaid-Coverage-and-Spending-in-Health-Reform-National-and-State-By-State-Results-for-Adults-at-or-Below-133-FPL.pdf (accessed 27.03.13).
26. Jones C.M., Campopiano M., Baldwin G., McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am. J. Public Health 2015, 105:e55-e63.
27. Jost T.S. Implementing health reform: four years later. Health Aff. (Millwood) 2014, 33:7-10.
28. The coverage gap: uninsured poor adults in states that do not expand Medicaid 2014, Kaiser Commission on Medicaid and the Uninsured, https://web.archive.org/web/20141114214443/http://kaiserfamilyfoundation.files.wordpress.com/2014/04/8505-the-coverage-gap_uninsured-poor-adults-in-states-that-do-not-expand-medicaid.pdf (accessed 24.06.15).
29. Knudsen H.K. The supply of physicians waivered to prescribe buprenorphine for opioid use disorders in the United States: a state-level analysis. J. Stud. Alcohol Drugs 2015, 76:644-654.
30. Krinn K., Karaca-Mandic P., Blewett L.A. State-based marketplaces using 'clearinghouse' plan management models are associated with lower premiums. Health Aff. (Millwood) 2015, 34:161-169.
31. Ling W., Smith D. Buprenorphine: blending practice and research. J. Subst. Abuse Treat. 2002, 23:87-92.
32. Mark T.L., Levit K.R., Yee T., Chow C.M. Spending on mental and substance use disorders projected to grow more slowly than all health spending through 2020. Health Aff. (Millwood) 2014, 33:1407-1415.
33. McLellan A.T., Lewis D.C., O'Brien C.P., Kleber H.D. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000, 284:1689-1695.
34. McLellan A.T., Woodsworth A.M. The Affordable Care Act and treatment for "substance use disorders:" implications of ending segregated behavioral healthcare. J. Subst. Abuse Treat. 2014, 46:541-545.
35. Mechanic D. More people than ever before are receiving behavioral health care in the United States, but gaps and challneges remain. Health Aff. (Millwood) 2014, 33:1416-1424.
36. Nadash P., Day R. Consumer choice in health insurance exchanges: can we make it work?. J. Health Polit. Policy Law 2014, 39:209-235.
37. Nielsen S., Dietze P., Dunlop A., Muhleisen P., Lee N., Taylor D. Buprenorphine supply by community pharmacists in Victoria, Australia: perceptions, experiences and key issues identified. Drug Alcohol Rev. 2007, 26:143-151.
38. Pating D.R., Miller M.M., Goplerud E., Martin J., Ziedonis D.M. New systems of care for substance use disorders: treatment, finance, and technology under health care reform. Psychiatr. Clin. N. Am. 2012, 35:327-356.
39. Paulozzi L.J., Mack K.A., Hockenberry J.M. Vital signs: variation among states in prescribing of opioid pain relievers and benzodiazapines - United States, 2012. MMWR 2014, 63:563-568.
40. Paulozzi L.J., Xi Y. Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol. Drug Saf. 2008, 17:997-1005.
41. Price C.C., Eibner C. For states that opt out of Medicaid expansion: 3.6 million fewer insured and $8.4 billion less in federal payments. Health Aff. (Millwood) 2013, 32:1030-1036.
42. Rabe-Hesketh S., Skronkal A. Multilevel and Longitudinal Modeling Using Stata 2012, vol. 1. Stata Press, College Station, TX. 3rd ed.
43. Rinaldo S.G., Rinaldo D.W. Availability without accessibility? State Medicaid coverage and authorization requirements for opioid dependence medications 2013, https://web.archive.org/web/20150304192426/http://www.asam.org/docs/default-source/advocacy/aaam_implications-for-opioid-addiction-treatment_final (accessed 22.12.14).
44. Roman P.M., Abraham A.J., Knudsen H.K. Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation. Addict. Behav. 2011, 36:584-589.
45. Rosenblatt R.A., Andrilla C.H.A., Catlin M., Larson E.H. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann. Fam. Med. 2015, 13:23-26.
46. Roy A.K., Miller M.M. The medicalization of addiction treatment professionals. J. Psychoact. Drugs 2012, 44:107-118.
47. Scott D. MAP: Obamacare's December enrollment surge 2014, https://web.archive.org/web/20150303004440/http://talkingpointsmemo.com/dc/obamacare-december-enrollment-surge (accessed 10.08.15).
48. Sommers B.D., Gunja M.Z., Finegold K., Musco T. Changes in self-reported insurance coverage, access to care, and health under the Affordable Care Act. JAMA 2015, 314:366-374.
49. Sommers B.D., Maylone B., Nguyen K.H., Blendon R.J., Epstein A.M. The impact of state policies on ACA applications and enrollment among low-income adults in Arkansas, Kentucky, and Texas. Health Aff. (Millwood) 2015, 34:1010-1018.
50. StataCorp Stata Multilevel Mixed-Effects Reference Manual: Release 13 2013, Stata Press, College Station, TX.
51. Stein B.D., Gordon A.J., Dick A.W., Burns R.M., Pacula R.L., Farmer C.M., Leslie D.L., Sorbero M. Supply of buprenorphine waivered physicians: the influence of state policies. J. Subst. Abuse Treat. 2015, 48:104-111.
52. Stein B.D., Pacula R.L., Gordon A.J., Burns R.M., Leslie D.L., Sorbero M., Bauhoff S., Mandell T., Dick A.W. Where is buprenorphine dispensed to treat opioid use disorders? The role of private offices, opioid treatment programs, and substance abuse treatment facilities in urban and rural counties. Milbank Q. 2015, 93:561-583.
53. Strang J., Manning V., Mayet S., Ridge G., Best D., Sheridan J. Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005. Addiction 2007, 102:761-770.
54. Substance Abuse and Mental Health Services Administration New Federal Law Increases Patient Limits 2009, https://web.archive.org/web/20090118144257/http://buprenorphine.samhsa.gov/federal.html (accessed 17.03.15).
55. Substance Abuse and Mental Health Services Administration Substance Abuse Treatment Facility Locator 2013, http://findtreatment.samhsa.gov/TreatmentLocator/faces/geographicSearch.jspx (accessed 12.06.13).
56. United States Census Bureau Census Regions and Divisions of the United States 2015, https://web.archive.org/web/20150226213756/http://www.census.gov/geo/maps-data/maps/pdfs/reference/us_regdiv.pdf (accessed 26.02.15).
57. United States Census Bureau State Totals: Vintage 2014 2015, https://web.archive.org/web/20150627072143/http://www.census.gov/popest/data/state/totals/2014/index.html (accessed 12.08.15).
58. Volkow N.D., Frieden T.R., Hyde P.S., Cha S.S. Medication-assisted therapies - tackling the opioid-overdose epidemic. N. Engl. J. Med. 2014, 370:2063-2066.
59. West J.C., Kosten T.R., Wilk J., Svikis D., Triffleman E., Rae D.S., Narrow W.E., Duffy F.F., Regier D.A. Challenges in increasing access to buprenorphine treatment for opiate addiction. Am. J. Addict. 2004, 13:S8-S16.